These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 17708273

  • 1. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease.
    Mokrowiecka A, Gasiorowska A, Malecka-Panas E.
    Hepatogastroenterology; 2007; 54(77):1443-8. PubMed ID: 17708273
    [Abstract] [Full Text] [Related]

  • 2. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
    Peeters M, Joossens S, Vermeire S, Vlietinck R, Bossuyt X, Rutgeerts P.
    Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
    [Abstract] [Full Text] [Related]

  • 3. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
    Koutroubakis IE, Petinaki E, Mouzas IA, Vlachonikolis IG, Anagnostopoulou E, Castanas E, Maniatis AN, Kouroumalis EA.
    Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689
    [Abstract] [Full Text] [Related]

  • 4. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
    Zholudev A, Zurakowski D, Young W, Leichtner A, Bousvaros A.
    Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
    [Abstract] [Full Text] [Related]

  • 5. Clinical utility of serological markers in inflammatory bowel disease.
    Mokrowiecka A, Daniel P, Słomka M, Majak P, Malecka-Panas E.
    Hepatogastroenterology; 2009 Nov; 56(89):162-6. PubMed ID: 19453050
    [Abstract] [Full Text] [Related]

  • 6. Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease.
    Reese GE, Constantinides VA, Simillis C, Darzi AW, Orchard TR, Fazio VW, Tekkis PP.
    Am J Gastroenterol; 2006 Oct; 101(10):2410-22. PubMed ID: 16952282
    [Abstract] [Full Text] [Related]

  • 7. The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China.
    Zhou F, Xia B, Wang F, Shrestha UK, Chen M, Wang H, Shi X, Chen Z, Li J.
    Clin Chim Acta; 2010 Oct 09; 411(19-20):1461-5. PubMed ID: 20570669
    [Abstract] [Full Text] [Related]

  • 8. [Interest of serologic markers in inflammatory bowel disease. About 105 cases].
    Fekih M, Ben Hlima S, Zitouni M, Matri S, Boubaker J, Makni S, Azza F.
    Tunis Med; 2007 Oct 09; 85(10):821-8. PubMed ID: 18236802
    [Abstract] [Full Text] [Related]

  • 9. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
    Mokrowiecka A, Gasiorowska A, Małecka-Panas E.
    Pol Merkur Lekarski; 2004 Oct 09; 17 Suppl 1():22-6. PubMed ID: 15603341
    [Abstract] [Full Text] [Related]

  • 10. [Diagnostic role of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].
    Gao X, Hu PJ, He Y, Liao SY, Peng S, Chen MH.
    Zhonghua Nei Ke Za Zhi; 2005 Jun 09; 44(6):428-30. PubMed ID: 16008854
    [Abstract] [Full Text] [Related]

  • 11. [p-ANCA and ASCA antibodies in the differential diagnosis between ulcerative rectocolitis and Crohn's disease].
    Lecis P, Germanà B, Papa N, Bertiato G, Doglioni C, Galliani E, Biedo FC.
    Recenti Prog Med; 2002 May 09; 93(5):308-13. PubMed ID: 12050913
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases.
    Kiliç ZM, Tunç B, Ayaz S, Filik L, Aktaş S, Parlak E, Ulker A.
    Turk J Gastroenterol; 2004 Dec 09; 15(4):238-42. PubMed ID: 16249978
    [Abstract] [Full Text] [Related]

  • 17. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.
    Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D.
    Gut; 1998 Jun 09; 42(6):788-91. PubMed ID: 9691915
    [Abstract] [Full Text] [Related]

  • 18. Immunological markers anti-saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: a helpful diagnostic tool.
    Montanelli A, Mainardi E, Vagni A, Villanacci V, Zambelli C, Cestari R, Cengia P, Minelli L, Missale G.
    Minerva Gastroenterol Dietol; 2005 Jun 09; 51(2):201-7. PubMed ID: 15990710
    [Abstract] [Full Text] [Related]

  • 19. Characteristics of inflammatory bowel disease serology in patients with indeterminate colitis.
    Sura SP, Ahmed A, Cheifetz AS, Moss AC.
    J Clin Gastroenterol; 2014 Apr 09; 48(4):351-5. PubMed ID: 24492405
    [Abstract] [Full Text] [Related]

  • 20. Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis.
    Dendrinos KG, Becker JM, Stucchi AF, Saubermann LJ, LaMorte W, Farraye FA.
    J Gastrointest Surg; 2006 Apr 09; 10(7):1060-4. PubMed ID: 16843878
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.